rdf-syntax-grammar
mods:
  schema location: http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-2.xsd
  title info:
    title: Immunosurveillance, immunodeficiencies and lymphoproliferations
    sub title: lymphoproliferative disorders in congenital and acquired immunodeficiencies
  name:
    name part: Oertel, S. (Stephan)
    name part: 1965-
  name:
    name part: Riess, Hanno B.
    name part: 1950-
  type of resource: text
  genre: bibliography
  origin info:
    place:
      place term: gw
    date issued: 2002
    issuance: monographic
  language:
    language term: eng
  physical description:
    form: print
    extent: x, 158 pages : illustrations ; 24 cm.
  table of contents: Immunosurveillance, immunodeficiency and lymphoproliferations -- Clinicopathological characteristics of post-transplant lymphoproliferative disorders -- Iatrogenic lymphoproliferative disorders in non-transplantation settings -- The role of Kaposi's Sarcoma-associated herpesvirus (KSHV/HHV-8) in lymphoproliferative diseases -- Dendritic cells for the induction of EBV immunity -- NF-[kappa]B inhibition in EBV-transformed lymphoblastoid cell lines -- Epstein-Barr viral load as a tool to diagnose and monitor post-transplant lymphoproliferative disease -- The role of immunosuppression in lymphoma -- Identification of prognostic factors in post-transplant lymphoproliferative disorders -- Methods and objectives of a large US multicenter case-control study of post-transplant lymphoproliferative disorder in renal transplant patients -- Antiviral treatment of Epstein-Barr virus-associated lymphoproliferations -- Low-dose chemotherapy for children with post-transplant lymphoproliferative disease -- Engineered antibody for treating lymphoma -- Treatment of post-transplant lymphomas with anti-B-cell monoclonal antibodies -- Epstein-Barr virus (EBV)-specific cytotoxic T lymphocytes for the prevention and treatment of EBV-associated post-transplant lymphomas -- Non-myeloablative stem cell transplantation for congenital immunodeficiencies -- Prognostic factors in the treatment of human immunodeficiency virus-associated non-Hodgkin's lymphoma -- Infusional CDE with Rituximab for the treatment of human immunodeficiency virus-associated non-Hodgkin's lymphoma : preliminary results of a phase I/II study
  note: S.H. Oertel, H. Riess (eds.).
  note: Includes bibliographical references and index.
  subject:
    topic: Lymphoproliferative Disorders
    topic: etiology
  subject:
    topic: Acquired Immunodeficiency Syndrome
    topic: complications
  subject:
    topic: Immune System
    topic: abnormalities
  subject:
    topic: Immunosuppression
    topic: adverse effects
  subject:
    topic: Monitoring, Immunologic
  classification: RC261 .R35 vol. 159
  classification: RC646.2
  classification: 616.99/4 s 616.99/442
  classification: W1 RE106P v.159 2002
  classification: WH 700 I335 2002
  related item:
    title info:
      title: Recent results in cancer research. 159
  identifier: 354042282X (hardcover : alk. paper)
  identifier: 2001049115
  record info:
    record content source: DNLM/DLC
    record creation date: 010713
    record change date: 20191203082117.0
    record identifier: in00004492982